These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 27988163)

  • 1. Accelerative Solid-State Oxidation Behaviour of Amorphous and Partially Crystalline Venetoclax.
    Afonso Urich JA; Marko V; Boehm K; Werner B; Zangger K; Saraf I; Paudel A; Kushwah V
    AAPS PharmSciTech; 2024 May; 25(5):114. PubMed ID: 38750299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the Degradation Chemistry of the Antitumor Agent Pemetrexed Disodium.
    Jansen PJ; Smith WK; Baertschi SW; Dorman DE; Kemp CAJ; McCune KA
    J Pharm Sci; 2016 Nov; 105(11):3256-3268. PubMed ID: 27539558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance.
    Baertschi SW; Maxwell-Backer L; Clemens M; Smitka TA; Draper JR; Taylor KW; Kaerner A; Jansen PJ
    J Pharm Sci; 2019 Sep; 108(9):2842-2857. PubMed ID: 30981754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
    Mahadik M; Bhusari V; Kulkarni M; Dhaneshwar S
    J Pharm Biomed Anal; 2009 Dec; 50(5):787-93. PubMed ID: 19615841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Degradation Chemistry of Farglitazar and Elucidation of the Oxidative Degradation Mechanisms.
    Reynolds DW; Campbell JM; Johnson BS; Joshi BK; Facchine KL; Long S; O'Connell TM; Paulus IV; Sides SL; Kraft ES; Wolters AM
    J Pharm Sci; 2017 Apr; 106(4):982-993. PubMed ID: 27988163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical degradation of proteins in the solid state with a focus on photochemical reactions.
    Mozziconacci O; Schöneich C
    Adv Drug Deliv Rev; 2015 Oct; 93():2-13. PubMed ID: 25481682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemometrics Approaches in Forced Degradation Studies of Pharmaceutical Drugs.
    Roberto de Alvarenga Junior B; Lajarim Carneiro R
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced degradation studies of biopharmaceuticals: Selection of stress conditions.
    Tamizi E; Jouyban A
    Eur J Pharm Biopharm; 2016 Jan; 98():26-46. PubMed ID: 26542454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced degradation of therapeutic proteins.
    Hawe A; Wiggenhorn M; van de Weert M; Garbe JH; Mahler HC; Jiskoot W
    J Pharm Sci; 2012 Mar; 101(3):895-913. PubMed ID: 22083792
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.